Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko purchased 61,300 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The stock was bought at an average cost of $0.43 per share, for a total transaction of $26,359.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Shares of Repro-Med Systems, Inc. (NASDAQ:REPR) traded up 0.238% during trading on Wednesday, hitting $0.421. 38,238 shares of the stock were exchanged. The stock has a market cap of $15.98 million and a PE ratio of 35.083. The firm has a 50 day moving average of $0.40 and a 200-day moving average of $0.39. Repro-Med Systems, Inc. has a 52-week low of $0.25 and a 52-week high of $0.59.
REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.
